Aurora Cannabis Inc. ACB has announced another round of reductions in its selling, general and administrative (SG&A) expense and consolidation of manufacturing facilities.
The latest announcements should allow the company to expand gross margins by as much as 8 percentage points, according to Cantor Fitzgerald.
The Aurora Cannabis Analyst
Cantor’s Pablo Zuanic maintained an Overweight rating for Aurora Cannabis, while raising the price target from 27 Canadian dollars ($19.89) to 29 Canadian dollars ($21.37).
The Aurora Cannabis Thesis
Talks with the CEO and CFO reveal that the planned cuts should neither disrupt production nor prevent Aurora Cannabis from capitalizing on market opportunities and delivering on its growth strategy, Zuanic said in the note.
He mentioned that the announcements included:
- SG&A of $40-$45 million per quarter in fiscal 2021, with reductions in corporate and production staff as well as third-party experts
- Completion of the consolidation of production facilities in Canada by January
- Inventory write-downs of $100 million
Although management did not issue any revenue guidance for the June quarter, the tone was “more upbeat” than its peer Canopy Growth CGC, which is losing share, the analyst said.
Aurora Cannabis confirmed that the industry had returned to steady growth. Zuanic added that the company had kept its EBITDA guidance unchanged at +$51 million for fiscal 2021.
Price Action
Shares of Aurora Cannabis were trading almost flat at $13.58 at the time of publication Wednesday.
Related Links
Why Aurora Cannabis Stock Is Trading Higher Today
Canopy Growth Analyst Sees Increasing Cannabis Market Share, Little Stock Upside
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!